Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
272.00
-5.3 (-1.91%)
BSENSE

Mar 16

BSE+NSE Vol: 1.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Mar'13
Sep'12
Net Sales
108.20
112.00
Other Operating Income
0.00
0.00
Total Operating income
108.20
112.00
Raw Material Cost
55.99
56.57
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
0.00
0.00
Power Cost
0.00
0.00
Manufacturing Expenses
4.75
4.29
Selling and Distribution Expenses
7.01
7.55
Other Expenses
0.10
-0.91
Total Expenditure (Excl Depreciation)
67.85
67.51
Operating Profit (PBDIT) excl Other Income
40.35
44.49
Other Income
-0.15
2.01
Operating Profit (PBDIT)
44.71
49.09
Interest
4.75
4.29
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
52.21
55.43
Depreciation
4.59
2.84
Profit Before Tax
35.36
41.96
Tax
12.95
13.50
Provisions and contingencies
0.00
0.00
Profit After Tax
21.94
27.88
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
21.94
27.88
Share in Profit of Associates
0.00
0.00
Minority Interest
0.47
0.58
Other related items
0.00
0.00
Consolidated Net Profit
22.41
28.46
Equity Capital
0.00
0.00
Face Value
10.0
10.0
Reserves
163.38
140.10
Earnings per share (EPS)
2.02
2.56
Diluted Earnings per share
2.02
2.56
Operating Profit Margin (Excl OI)
37.21%
39.5%
Gross Profit Margin
36.93%
40.0%
PAT Margin
20.28%
24.89%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Mar 2013 is -3.39%

stock-summary

Consolidate Net Profit

Growth in half year ended Mar 2013 is -21.26%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Mar 2013 is -4.74%

stock-summary

Interest

Growth in half year ended Mar 2013 is 10.72%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Mar 2013 has fallen from Sep 2012

Compare Half Yearly Results Of Advanced Enzyme With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
108.20
1,243.30
-1,135.10
-91.30%
Other Operating Income
0.00
0.00
0.00
Total Operating income
108.20
1,243.30
-1,135.10
-91.30%
Raw Material Cost
55.99
742.31
-686.32
-92.46%
Purchase of Finished goods
0
59.26
-59.26
-100.00%
(Increase) / Decrease In Stocks
0
-19.89
19.89
100.00%
Employee Cost
0.00
63.87
-63.87
-100.00%
Power Cost
0
0.00
0.00
Manufacturing Expenses
4.75
0.00
4.75
Selling and Distribution Expenses
7.01
0.00
7.01
Other Expenses
0.10
239.38
-239.28
-99.96%
Total Expenditure (Excl Depreciation)
67.85
1,084.93
-1,017.08
-93.75%
Operating Profit (PBDIT) excl Other Income
40.35
158.37
-118.02
-74.52%
Other Income
-0.15
0.40
-0.55
-137.50%
Operating Profit (PBDIT)
44.71
158.77
-114.06
-71.84%
Interest
4.75
16.27
-11.52
-70.81%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
52.21
142.50
-90.29
-63.36%
Depreciation
4.59
30.98
-26.39
-85.18%
Profit Before Tax
35.36
111.52
-76.16
-68.29%
Tax
12.95
12.39
0.56
4.52%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
21.94
99.13
-77.19
-77.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0.00
0.00
Other Adjustments
0
0.00
0.00
Net Profit
21.94
99.13
-77.19
-77.87%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.47
0.06
0.41
683.33%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
22.41
99.19
-76.78
-77.41%
Equity Capital
0
91.27
-91.27
-100.00%
Face Value
10.00
10.00
0.00
Reserves
163.38
0.00
163.38
Earnings per share (EPS)
2.02
10.87
-8.85
-81.42%
Diluted Earnings per share
2.02
10.86
-8.84
-81.40%
Operating Profit Margin (Excl OI)
37.21%
12.74%
0.00
24.47%
Gross Profit Margin
36.93%
11.46%
0.00
25.47%
PAT Margin
20.28%
7.97%
0.00
12.31%
Public Share Holdings (%)
0%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 108.20 Cr
in Mar 2013

Figures in Cr
stock-summary

Growth in half year ended Mar 2013 is -3.39%

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 22.41 Cr
in Mar 2013

Figures in Cr
stock-summary

Growth in half year ended Mar 2013 is -21.26%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 44.85 Cr
in Mar 2013

Figures in Cr
stock-summary

Growth in half year ended Mar 2013 is -4.74%

Half Yearly - Interest
Interest 4.75 Cr
in Mar 2013

Figures in Cr
stock-summary

Growth in half year ended Mar 2013 is 10.72%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.21%
in Mar 2013

Figures in %
stock-summary

Growth in half year ended Mar 2013 has fallen from Sep 2012